# FDA Inspection 1086695 - Wuxi Biologics Co Ltd - April 16, 2019

Source: https://www.keypedia.com/records/fda_inspections/wuxi-biologics-co-ltd/3f7bec85-d20f-4678-b413-0fe5b6e2ca13
Source feed: FDA_Inspections

> FDA Inspection 1086695 for Wuxi Biologics Co Ltd on April 16, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1086695
- Company Name: Wuxi Biologics Co Ltd
- Inspection Date: 2019-04-16
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1274331 - 2024-06-04](https://www.keypedia.com/records/fda_inspections/wuxi-biologics-co-ltd/a2f41bd6-a321-4f88-9e90-c2d466d200a0)
- [FDA Inspection 1219694 - 2023-05-09](https://www.keypedia.com/records/fda_inspections/wuxi-biologics-co-ltd/c3c4a4dd-ac1d-4b71-9bdd-d7418636447c)
- [FDA Inspection 1137612 - 2021-04-02](https://www.keypedia.com/records/fda_inspections/wuxi-biologics-co-ltd/6cadb85b-a7b3-4a90-b407-1652d090134e)

Company: https://www.keypedia.com/companies/wuxi-biologics-co-ltd/67a28116-624d-42f6-adae-18cf80094862

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c